Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phylogenetic lineages of tuberculosis isolates and their association with patient demographics in Tanzania.
Mutayoba BK, Michael Hoelscher, Heinrich N, Joloba ML, Lyamuya E, Kilale AM, Range NS, Ngowi BJ, Ntinginya NE, Mfaume SM, Wilfred A, Doulla B, Lyimo J, Kisonga R, Kingalu A, Kabahita JM, Guido O, Kabugo J, Adam I, Luutu M, Namaganda MM, Namutebi J, Kasule GW, Nakato H, Byabajungu H, Lutaaya P, Musisi K, Oola D, Mboowa G, Pletschette M. Mutayoba BK, et al. Among authors: byabajungu h. BMC Genomics. 2022 Aug 5;23(1):561. doi: 10.1186/s12864-022-08791-3. BMC Genomics. 2022. PMID: 35931954 Free PMC article.
Molecular characterisation of second-line drug resistance among drug resistant tuberculosis patients tested in Uganda: a two and a half-year's review.
Mujuni D, Kasemire DL, Ibanda I, Kabugo J, Nsawotebba A, Phelan JE, Majwala RK, Tugumisirize D, Nyombi A, Orena B, Turyahabwe I, Byabajungu H, Nadunga D, Musisi K, Joloba ML, Ssengooba W. Mujuni D, et al. Among authors: byabajungu h. BMC Infect Dis. 2022 Apr 11;22(1):363. doi: 10.1186/s12879-022-07339-w. BMC Infect Dis. 2022. PMID: 35410160 Free PMC article.
First report of whole-genome analysis of an extensively drug-resistant Mycobacterium tuberculosis clinical isolate with bedaquiline, linezolid and clofazimine resistance from Uganda.
Kabahita JM, Kabugo J, Kakooza F, Adam I, Guido O, Byabajungu H, Namutebi J, Namaganda MM, Lutaaya P, Otim J, Kakembo FE, Kanyerezi S, Nabisubi P, Sserwadda I, Kasule GW, Nakato H, Musisi K, Oola D, Joloba ML, Mboowa G. Kabahita JM, et al. Among authors: byabajungu h. Antimicrob Resist Infect Control. 2022 May 12;11(1):68. doi: 10.1186/s13756-022-01101-2. Antimicrob Resist Infect Control. 2022. PMID: 35550202 Free PMC article.
Rifampicin susceptibility discordance between Xpert MTB/RIF G4 and Xpert Ultra before MDRT-TB treatment initiation: A case report from Uganda.
Ssengooba W, Komakech K, Namiiro S, Byabajungu H, Nalunjogi J, Katagira W, Kimuli I, Joloba ML, Adakun S, Nakiyingi L, Torrea G, Kirenga BJ. Ssengooba W, et al. Among authors: byabajungu h. J Clin Tuberc Other Mycobact Dis. 2021 Nov 6;25:100286. doi: 10.1016/j.jctube.2021.100286. eCollection 2021 Dec. J Clin Tuberc Other Mycobact Dis. 2021. PMID: 34816021 Free PMC article.